Sarepta’s flash firing tightens the focus on a heavily scrutinized company

Damian Garde Sarepta Therapeutics' terse dismissal of its top scientist on Thursday has led to a swirl of rumors and anonymous-sourced reports of boardroom clashes, incompatible ...

Rottapharm founders price IPO valuing company at up to $2.46 billion

Tracy Staton Two years ago, Rottapharm's founding family gave up on selling a big stake in the company. Word was, the offers didn't quite measure up to the asking price–and ...

Forest CEO Saunders to lead combined company after Actavis buyout

Alok Saboo FierceBiotech News

Buzz: If it’s an Irish biopharma company, it’s on analysts’ M&A list

John Carroll Ireland-based biopharma companies are all the rage these days. Blessed by advantageous tax laws, Elan and Warner Chilcott fell to takeover bids. And now that Jazz Pharmaceuticals ...

Pfizer exec Amy Schulman talks gender, power and company policy

Tracy Staton Soon to lead a new vaccines, oncology and consumer health division at Pfizer, Schulman says ambitious women need to speak up, spend their political capital and stop ...

Novartis Becomes First Company to Earn CEO Cancer Gold Standard

mia.burns Novartis first company accredited with global “CEO Cancer Gold Standard” for outstanding efforts in cancer prevention and treatment   The non-profit ...

Transfer of Business of Takeda Bio Development Center to its Parent Company

mia.burns — Takeda’s New Structure for Oncology Development Functions — Osaka Japan, August 1, 2013 — Takeda Pharmaceutical Company Limited (“Takeda”) ...

Industry Voices: The Zero-Person Biotech Company

Alok Saboo In recent years, it has become dramatically easier and quicker to create a virtual drug-development company. Today it is even possible to take virtual to its logical extreme: ...

Gilead earnings firm, but company gets shot in arm from Vertex setback

Eric Palmer Gilead Sciences turned in second-quarter earnings that were pretty much in line with analysts' projections Thursday, then caught a break in the same day that pushed ...

Pharma Company Acquires Rights to Antiviral Product Line for China

barbara.lempert Marinomed Biotechnologie GmbH: Pharma Company Acquires Rights to Antiviral Product Line for China MAVIREX® technology is the basis for five products against viral ...

Ark Therapeutics Group plc Company Update

barbara.lempert London, UK, 9 July 2013 – Ark Therapeutics Group plc (LSE: AKT) (“Ark”) confirms that the contract with Crawford Healthcare relating to the sale of ...

Blackfield Announces Fourth Major Pharmaceutical Company Collaboration

barbara.lempert Cologne, Germany, July 9, 2013 / B3C newswire / – Blackfield announced today that it has entered a collaboration with AstraZeneca, a global biopharmaceutical ...
Page 1 of 212
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS